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OBSERVATIONS ON THE MASSIVE DOSE ARSENO-
THERAPY OF EARLY SYPHILIS BY THE INTRA-
VENOUS DRIP METHOD
II. ELECTROCARDIOGRAPHIC ABNORMALITIES ASSOCIATED WITH
MASSIVE ARSENOTH'ERAPY*
ARTHUR J. GEIGER, BRANCH CRAIGE JR.,
AND JOSEPH F. SADUSK JR.
The massive dose chemotherapy of early syphilis by the con-
stant intravenous drip method has been extensively studied by
Hyman and his associates.', 3', The application and further study
of massive arsenotherapy at the New Haven Hospital, detailed in a
preceding report,10 soon disclosed hitherto unappreciated electro-
cardiographic changes associated with this formn of therapy.9
The growing popularity of massive arsenotherapy of syphilis,
and the criticism by Moore8 that insufficient toxicological research
underlies the general clinical acceptance of this method, have
prompted the more detailed study of the electrocardiographic effects
presented herewith.
Methods and procedure
Serial electrocardiograms, including the conventional limb leads and pre-
cordial lead IV-F, were obtained on 23 patients with early syphilis who were
treated daily for 5 days with 240 mgm. of Mapharsen dissolved in 2400 cc.
of 5 per cent glucose solution and given intravenously by the constant-drip
technic over a 12-hour period each day.
All of the subjects in this study were less than 40 years old, except one
who was 42 years of age. All were apparently free from cardiovascular
disease as determined from the history, physical examination including blood
pressure, roentgenological study of the heart, and one or more electrocardio-
grams obtained prior to treatment. Additional electrocardiograms were
sometimes recorded during the 5 days of the treatment; in three instances
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TABLE 1
ELECTROCARDIOGRAPHIC CHANGES WITH
T-W A V E
Follow-up
DuringI$ v . B re (days) (days) (weeks) (months)
w R .^ w ~eki1 2: 3: 4 :5 I: 2: 3 :4 : 2 :3 :4 2 :3: 4:
M M :22:F :S : 2.5 : -440: 4.5:
A P :21:F :S : 9.5 . 1.5 :11.0:
A Fo :39:M:P : 9.0 : : : -1.0: 6.5:
S G :20:M:S 11.5:11.0 7.5:10.0: 8.0: 4.0: 4.0 3.5: 5.5: 6.0
J Ba :26:M:P : 7.5 -0.: 7.0:
A K :36:F :S : 3.5 :-1. :
O P :19:M:P :19.0 : : : 9.0: :20.0:
J Bo :20:M:P :14.5 ; 8.5: 18.5:
E S :42:M:S : 5.0 0.0: 7.5: 8.5:
C B :21:M:S : 9.0 : : 4.0: 8.5: :10.5:
M R :20:F :S :13.0 : 8.0: 14.0:
C C :22:F :S 7.5: 7.5 6.0: 4.0: 4.0: 3.0: 3.0 1.0: 4.0: 4.5: 6.0: : 7.5: 9.0:
E P :18:M:P :11.5 6.5: : 6.0: 7.0 : 8.0: 7.0:
G H :22:F :S : 9.5 : : 1.5 : : 8.0: 11.5:14.0:
J M :22:M:P :14.0 : 8.5: 7.0 : :
J M :22:M:P :19.5 95 : : :
D F :20:F :S :11.0 3.5 : : : :9.0:
R I :23:M:P :12.0 7.0 : : : 1.5:
M F :28:F :S :9.0 7.5: 6.5 : : : :
M F :28:F: :9.5 8.5 : : 12.0: :
D Mc :21:M:P : 6.5 6.0 : : 10.0:
F D :37:F :S :5.0 5.5 : : :
R R :25:F: :3.0 : 2.5: 1.5: :3.0
V I :33:F :S :3.5 0.5: 1.:-0.5:-2.0:-1.5 -252.0: : : 4.0: :
A Fr :20:F :S :4.5 : 2.5: : 4.0 : :
* Syphilis; S = secondary; P primary
t The T-wave amplitude is represented by the algebraic sum in all four leads
t Fever- secondary fever
§ Vomiting is graded in severity; +=1 or 2 times; ++=3 to 9 times; +++=10 to 19 times
daily recordings were made. Electrocardiograms were always obtained
immediately after the conclusion of therapy and periodically during the next
several weeks or months. All tracings were obtained with the patients semi-
recumbent to exclude alterations attributable to changes in position. The
galvanometer was standardized to a sensitivity of 1 cm. deflection per 0.1 mv.,
and all measurements were properly corrected for any error in standardization.
Results
Either during the course of treatment or immediately after its
termination all but three subjects (cases D. Mc., F. D., and R. R.,
Table 1) showed changes in the T waves characterized by diminu-
tion in amplitude (Fig. 1) or disappearance or reversal of an origi-
nally upright deflection (Figs. 2 and 3) with subsequent return to
positive waves that were equal to or greater than those in the pre-
vious control tracings. In all but one (case M. F., Table 1) of
the observations with positive results the changes were consideredTHE ELECTROCARDIOGRAM IN MASSIVE ARSENOTHERAPY 359
TABLE 1-(continued)
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signilficant in degree, and in no instance was the change in T confined
to lead III. The alteration in the T waves was always concordant in
all leads, never reciprocal. Two of the four cases with negative
results pertained to patients who received a'second course of massive
Mapharsen treatment; one for failure of the serology to become
negative after the first course, the other because ofserological relapse
(subjects M. F., and R. R. respectively, of Table 1).
Table 1 summarizes the T-wave alterations in relation to the
course of treatment and clinical features. The T.-wave values in the
table represent the algebraic sum of T-wave amplitudes for the
four leads of each electrocardiographic study. This device was
employed to conserve space, and it seemed valid inasmuch as the
changes in T waves were consistently concordant.
Discussion
The nature and magnitude of the T-wave changes in the great
majority of the cases clearly establish them as abnormal. Changes
of lesser degree in the other cases might be regarded as of question-YALE JOURNAL OF BIOLOGY AND MEDICINE
able significance were it not for the fact that these smaller alterations
differed only in degree from the definitely abnormal ones and, with-
out exception, were uniformly in the same direction, namely, a dimi-
nution of T-wave amplitude associated with treatment and a return
to the control values in the follow-up period. The uniform trend
and general magnitude of the T-wave changes in these experiments
are graphically presented in Figure 4, where again the values for T
represent the algebraic sum of the amplitudes in the four leads.
Having demonstrated that significant electrocardiographic
changes almost invariably attend massive arsenotherapy, the next
logical question is concerned with the nature and cause ofthe changes.
None of the patients had apparent cardiovascular disease prior to
treatment, and none developed clinical evidence of such involve-
ment either during the treatment course or in subsequent weeks or
months. The general course of the curves in Figure 4 and daily
electrocardiographic studies during the period of hospitalization in
three patients indicate that the abnormalities developed progres-
sively during the five-day treatment period. They were usually
maximal on the day following the completion of therapy, and then
steadily regressed to regain the normal control values within a few
weeks.
The actual cause of the changes can only be surmised from our
data after exclusion of factors which do not seem concerned. Among
these are the following:
Age, sex, and color, and the stage of syphilis. Our small group
showed no apparent correlation between these factors and the occur-
rence of electrocardiographic changes.
Secondary fever. A recent review and report of experiments by
Knies' indicated that minor T-wave changes of brief duration might
result from induced hyperthermia, but the effects seen in the
majority of our experiments were notably greater than those
described by Knies with body temperatures hieher than those of our
subjects, and our electrocardiographic effects persisted longer than
would appear likely were they due to fever. Moreover, some of
our patients with T-wave changes had no fever.
Disturbances in acid-base equilibrium. Vomiting, which was com-
mon in our patients but was usually not severe, might lead to alka-
losis which, according to observations of Barker and his associates,2
can be associated with lowering of the amplitude of the T wave.
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more consistent in occurrence than those described with alkalosis.
Moreover, in most of our patients the vomiting seemed hardly
sufficient to result in significant alkalosis, but unfortunately chemical
studies to confirm this impression were not available. It is also
noteworthy that when vomiting occurred it was usually early in the
treatment period, while the most pronounced electrocardiographic
changes occurred at or just after the termination of treatment.
Finally, the same T-wave changes were observed in patients who
did not vomit, and one subject (J. M., re-treated for reinfection),
who manifested the T-wave alteration in two courses of treatment,
vomited considerably with the first course but not at all with the
second.
Herxheimer reaction. Mild or severe reactions (the latter sig-
nifying a rectal temperature of 1010 or higher) occurred in the
majority of our patients, and cardiovascular participation in such
reactions might readily be associated with electrocardiographic
changes, particularly in the T wave. Wilson"1 long ago drew atten-
tion to this event in patients with known cardiovascular syphilis, and
his observation has been amply confirmed. The selection of our
patients, however, was based in part on their being apparently free
from cardiovascular disease. Ofthe patients selected none developed
clinical evidence of such complication during or after the treatment
and there is no evidence that electrocardiographic changes accom-
pany Herxheimer reactions resulting from ordinary doses of the
arsenical drugs conventionally employed in the treatment of syphilis
in patients without symptoms or signs of cardiovascular involve-
ment. More significant from the standpoint of exclusion of the
Herxheimer phenomenon as a cause of the electrocardiographic
changes are the following observations: Six patients (subjects A. F.,
D. F., A. Fr., M. R., J. M., and V. I., Table 1) showed the T-wave
changes in the absence of any reaction; and three (subjects E. P.,
A. Fr., V. I., Table I) who had received a preliminary injection of
the usual small standard dose of Mapharsen with resulting Herx-
heimer reactions showed no changes in daily records obtained during
the time when such effects were usually encountered with the mas-
sive dose treatment.
Volume of injected fluid. It is most unlikely that the 2400 cc.
of 5 per cent glucose solution with which the drug was slowly
injected (200 cc. per hour) would influence the electrocardiogram in
patients with normally functioning hearts, and no such electrocardio-YALE JOURNAL OF BIOLOGY AND MEDICINE
graphic effects have apparently ever been noted in association with
the even more rapid infusions ofglucose as are given daily in hospital
practice.
Toxic effect of arsenic. A recent report of necropsy studies of
dogs following the injection of massive doses of arsenic' revealed no
significant or constant gross or microscopic abnormalities in the heart,
and none have been reported in the few fatal human cases recorded.4
Wilson"1 found no electrocardiographic changes associated with
the first course of arsphenamine injections in 20 syphilitic patients
who were apparently free from cardiovascular involvement and who
received the usual small doses of arsphenamine in the conventional
method of treatment. The absence of electrocardiographic changes
in four of our patients who had received a standard small prelimi-
narydose of Mapharsen, and the subsequent development of T-wave
alterations with the massive dose treatment would imply that the
electrocardiographic abnormalities attending massive arsenotherapy
represent toxic arsenic effects on the heart, and their transient nature
suggests that the myocardial effect is a benign one similar, perhaps,
to that of digitalis or quinidine.
Summary and conlusions
Serial electrocardiograms obtained before, during, and after mas-
sive arsenotherapy in 23 patients (25 experiments) with early
syphilis revealed significant abnormalities during or shortly after the
treatment in 21 of the experiments.
The principal changes were concordant diminution of the ampli-
tude of the T wave in all leads, and frequently inversion of T in
leads other than the third.
The effects appeared most pronounced toward the end of the
treatment course or immediately thereafter, and in every case the
altered electrocardiographic features returned to the pre-treatment
control values within a few weeks.
The electrocardiographic effects occurred equally in patients with
primary or secondary syphilis; they were not apparently related
to the occurrence of Herxheimer reactions, secondary fever, or vom-
iting; they were not seen after the preliminary injection of small
standard doses of Mapharsen; and no clinical evidence of cardiac
injury was evident in the presence of the T-wave changes.
It is probable that the electrocardiographic abnormalities repre-
sented toxic arsenic effects of a transient and benign nature.
362THE ELECTROCARDIOGRAM IN MASSIVE ARSENOTHERAPY 363
REFERENCES
I Baehr, G., Leifer, W., Chargin, L., Hyman, H. T., Mahoney, J. F., Webster,
B., Thomas, E., Sobotka, H., Mann, W., Feldbau, E., and Rice, J. L.:
Arch. Dermat. & Syph., 1940, 42, 239.
2 Barker, P. S., Shrader, E. L., and Ronzoni, E.: Am. Heart J., 1939, 17, 169.
3 Chargin, L., Leifer, W., and Hyman, H. T.: J. Am. Med. Asso., 1935, 104,
878.
4 Elliot, D., Baehr, G., Shaffer, L., Usher, G. S., and Lough, S. A.: J. Am. Med.
Asso., 1941, 117, 1160.
5 Hyman, H. T., Chargin, L., Rice, J. L., and Leifer, W.: J. Am. Med. Asso.,
1939, 113, 1208.
6 Knies, P.: Am. Heart J., 1941, 22, 804.
7 Magnuson, H. J., Raulston, B. O., and Muff, A.: Venereal Disease Information,
1941, 22, 157.
8 Moore, J. E.: Am. J. Syph., Gonor., and Ven. Dis., 1939, 23, 797.
9 Sadusk, J. F. Jr.: Discussion of papers of Leifer, Chargin, and Hyman, and of
Elliot, Baehr, Shaffer, Usher, and Lough: J. Am. Med. Asso., 1941,
117, 1165.
10 Sadusk, J. F. Jr., Craige, B. Jr., Brookens, N., Poole, A. K., and Strauss, M. J.:
Yale J. Biol. & Med., 1942, 14, 333.
11 Wilson, F. N.: Libman Anniv. Vols., 1932, 3, 1237.